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Sexual Dysfunction
Assessing Quality of Life Related to Voiding Symptoms and Sexual 
Function in Menopausal Women
Jae Doo Um, Dong Il Kang, Jang Ho Yoon, Kweon Sik Min
Department of Urology, Inje University Busan Paik Hospital, Inje University College of Medicine, Busan, Korea
Purpose: To evaluate the correlation between lower urinary tract symptoms (LUTS) 
and premature ejaculation (PE) in Korean men older than 40 years.
Materials and Methods: In total, 258 men older than 40 years completed the 
International Prostate Symptom Score (IPSS; total score, storage symptoms [ST], and 
voiding symptoms [VD]), a 5-item version of the International Index of Erectile 
Function (IIEF-5), and the Premature Ejaculation Diagnostic Tool (PEDT). The study 
examined the relationship between LUTS and PE. In the PEDT, PE is defined as a score 
≥11.
Results: The prevalence of PE was 29.1% with the PEDT versus a self-reported value 
of 49.5%. The prevalence of PE was 30.9% in 40 to 59-year-old men (21.3%) and 28.1% 
in 60 to 79 year-old men (78.7%). In men 40 to 59 and 60 to 79 years old, the mean PEDT, 
IPSS, and IIEF-5 scores were 8.65 and 7.88, 13.5 and 12.38, and 15.83 and 13.69, 
respectively. No significant correlations were observed between the total and subscale 
scores of the IPSS (p=0.204) and the PEDT (p=0.309) with increasing age, whereas a 
significant negative correlation was detected between the IIEF-5 and age (p=0.002). 
The PEDT score was significantly correlated with the IPSS-ST (r=0.326, p＜0.001), 
IPSS-VD (r=0.183, p=0.005), IPSS-total (r=0.310, p＜0.001), and IIEF-5 total (r=-0.248,
p＜0.001).
Conclusions: LUTS, especially storage symptoms, were related to PE. In elderly men, 
control of both erectile dysfunction and LUTS may play an important role in managing 
PE.
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INTRODUCTION
Worldwide, the human life span and the proportion of eld-
erly people in the population have both increased. Various 
changes occur in the human body with age. In elderly men, 
lower urinary tract symptoms (LUTS) and sexual dysfunc-
tion often appear concurrently. Several community-based 
studies have shown strong correlations between the preva-
lence of sexual dysfunction, especially erectile dysfunction 
(ED), and the severity of LUTS with increasing age. This 
coexistence of sexual problems with LUTS negatively af-
fects the quality of life (QoL) [1]. The prevalence of LUTS 
and sexual dysfunction increases with age in Korea, and 
both present synchronously in many cases. Consequently, 
effort has been directed at determining the pathophysiol-
ogy common to these conditions, including hyperactive 
adrenergic signaling, increased Rho-kinase and endothe-
lium activity, and decreased nitric oxide (NO) levels in gen-
ital tissue.
Premature ejaculation (PE) is also seen in the elderly as 
a primary or secondary condition. In many countries, the 
prevalence of PE in most decades is similar, about 20 to 30% 
[2]. By contrast, in Korea, the prevalence of PE in the sixth 
decade is 36.8% vs. 24.6% in the third decade [3]. The reason 
for the increased prevalence of PE with age has not been 
determined, but it could be related to conditions such as Korean J Urol 2012;53:189-193
190 Um et al
TABLE 1. Correlation of the questionnaire scores with age
Age (yr) 40-59 60-79 Total
n=55 (21.32%)
mean±SD
n=203 (78.68%)
mean±SD
n=258
mean±SD
p-value
IPSS-ST
IPSS-VD
IPSS-total
IIEF-5
PEDT
  5.57±3.848
  7.93±6.416
13.50±9.350
15.83±5.427
  8.65±4.934
  5.26±3.502
  6.94±4.989
12.38±8.027
13.69±5.833
  7.88±4.894
  5.42±3.675
  7.20±5.385
12.67±8.364
14.14±5.805
  8.05±4.903
0.081
0.413
0.204
0.002
0.309
Values are presented as mean±SD.
IPSS total, International Prostate Symptom Score total score; IPSS-ST, IPSS storage symptoms domain; IPSS-VD, IPSS voiding symp-
toms domain score; IIEF-5 total, International Index of Erectile Function total score; PEDT, Premature Ejaculation Diagnostic Tool.
TABLE 2. Correlation of the IPSS and IIEF-5 with PEDT (age, 40 
to 59)
PEDT (n=55) IIEF (n=55)
rp - v a l u e r   p - v a l u e
IPSS-ST
IPSS-VD
IPSS-total
IIEF-5
0.327
0.223
0.284
-0.323
0.077
0.235
0.128
0.018
-0.222 
-0.096 
-0.192 
-
0.255
0.628
0.327 
-
r, correlation coefficient; IPSS total, International Prostate 
Symptom Score total; IPSS-ST, IPSS storage symptoms domain; 
IPSS-VD, IPSS voiding symptoms domain; IIEF-5, IIEF total 
score; PEDT, Premature Ejaculation Diagnostic Tool; r, correla-
tion coefficient.
LUTS and ED.
If the increased prevalence of PE during old age in Korea 
is the result of increasing secondary PE compared to pri-
mary PE [3], then a correlation may exist between ED or 
LUTS in middle-aged to elderly men with PE. Therefore, 
this study examined the correlations among LUTS, ED, 
and PE in Korean men older than 40 years.
MATERIALS AND METHODS
This study enrolled 258 men older than 40 years presenting 
between June 2010 and March 2011 in Busan, Korea. All 
subjects were from the general population and had partici-
pated in a health care lecture in Busan. Men between 40 
and 79 years old who were willing and able to participate 
in the study were included. Subjects who were younger 
than 40 years old or older than 79 years old were excluded. 
The study had a cross-sectional design.
All subjects were assessed by using the International 
Prostate Symptom Score (IPSS), a 5-item version of the 
International Index of Erectile Function (IIEF-5) from the 
ED domain of the IIEF [4], and a validated Korean version 
of the Premature Ejaculation Diagnostic Tool (PEDT) [5]. 
A PEDT score ≥11 was categorized as PE. The IPSS was 
categorized into the total score, storage symptoms (ST), 
and voiding symptoms (VD). The relationships among the 
storage symptoms, voiding symptoms, IIEF-5 scores, and 
PEDT scores were analyzed.
The statistical analyses were performed by using SPSS 
ver. 17.0 (SPSS Inc., Chicago, IL, USA). Student’s t-test 
was used to examine the differences in the IPSS-ST, 
IPSS-VD, IPSS-total, IIEF-5, and PEDT between the age 
groups. Spearman’s rank correlation analysis was used to 
examine the correlations of the IPSS and IIEF-5 with the 
PEDT and each other. The correlation analyses were strati-
fied by patient age. The results were considered statisti-
cally significant when p＜0.05.
RESULTS
The study enrolled 258 men: 55 (21.32%) were 40 to 59 years 
old and 203 (78.68%) were 60 to 79 years old. The mean 
IPSS, IIEF, and PEDT were 12.67, 14.14, and 8.05, respec-
tively. Using the PEDT, the prevalence of PE was 29.1% 
versus a self-reported incidence of 49.5%.
Comparing the age groups (40 to 59 vs. 60 to 79 years old), 
no significant correlations were observed in the total and 
subscale scores of the IPSS and PEDT (IPSS-ST, p=0.081; 
IPSS-VD, p=0.413; IPSS-total, p=0.204; PEDT, p=0.309). 
However, a significant negative correlation was detected 
between the IIEF score and age (p=0.002). The mean±SD 
IIEF-5 score was 15.83±5.427 in those aged 40 to 59 years 
old and 13.69±5.833 in those aged 60 to 79 years old (Table 
1).
Comparing the assessment scales in the 40 to 59 year-old 
age group, the PEDT score was significantly correlated 
with IIEF (r=-0.323, p=0.018), but was not correlated with 
IPSS-ST (r=0.327, p=0.077), IPSS-VD (r=0.223, p=0.235), 
or IPSS-total (r=0.284, p=0.128). The IIEF-5 score was not 
correlated with IPSS-ST (r=-0.222, p=0.255), IPSS-VD (r= 
-0.096, p=0.628), or IPSS-total (r=-0.192, p=0.327) (Table 
2). 
Comparing the assessment scales in the 60 to 79 year-old 
age group, the PEDT score was significantly correlated 
with the IPSS-ST (r=0.318, p=0.003), IPSS-total (r=0.292, 
p=0.007), and IIEF-5 (r =-0.250, p＜0.001), but was not cor-
related with the IPSS-VD (r=0.196, p=0.075). The IIEF-5 
score was significantly negatively correlated with the Korean J Urol 2012;53:189-193
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TABLE 3. Correlation of the IPSS and IIEF-5 with PEDT (age, 60 
to 79)
 PEDT (n=203) IIEF (n=203)
r p-value r p-value
IPSS-ST
IPSS-VD
IPSS-total
IIEF-5
0.318
0.196
0.292
-0.250
0.003 
0.075 
0.007 
0.000 
-0.158
-0.174 
0.079 
- 
0.162
0.122
-0.197 
-
r, correlation coefficient; IPSS total, International Prostate 
Symptom Score total; IPSS-ST, IPSS storage symptoms domain; 
IPSS-VD, IPSS voiding symptoms domain; IIEF-5, IIEF total 
score; PEDT, Premature Ejaculation Diagnostic Tool; r, correla-
tion coefficient.
TABLE 4. Correlation of each domain of the IIEF-5 with each domain of the PEDT 
IIEF-5
PEDT question, r (p-value)
No. 1
a No. 2
b No. 3
c No. 4
d No. 5
e
1. Erection confidence
2. Erection firmness
3. Maintenance frequency
4. Maintenance ability
5. Intercourse satisfaction
-0.255 (0.000)
-0.206 (0.001)
-0.165 (0.009)
-0.289 (0.000)
-0.296 (0.000)
-0.091 (0.153)
-0.112 (0.077)
-0.018 (0.779)
-0.069 (0.281)
-0.174 (0.006)
-0.092 (0.146)
-0.015 (0.813)
-0.011 (0.864)
-0.080 (0.207)
-0.180 (0.004)
-0.193 (0.002)
-0.157 (0.013)
-0.141 (0.027)
-0.249 (0.000)
-0.298 (0.000)
-0.237 (0.000)
-0.163 (0.010)
-0.192 (0.002)
-0.299 (0.000)
-0.320 (0.000)
IIEF, International Index of Erectile Function; PEDT, Premature Ejaculation Diagnostic Tool; r, correlation coefficient. 
a: How difficult is it for you to delay ejaculation (ejaculation control)?, 
b: Do you ejaculate before you want to (frequency of premature 
ejaculation)?, 
c: Do you ejaculate with very little stimulation (ejaculation with minimal sexual stimulation)?, 
d: Do you feel frustrated 
because you ejaculate before you want to (distress)?, 
e: How concerned are you that your time to ejaculation leaves your partner sexually 
unfulfilled (interpersonal difficulty)?.
FIG. 1. Significant correlation between Premature Ejaculation 
Diagnostic Tool score and International Prostate Symptom 
Score (IPSS)-storage symptoms domain in men aged 60 to 79 
years (n=203).  
PEDT (r =-0.250, p＜0.001), but was not correlated with the 
IPSS-ST (r=-0.158, p=0.162), IPSS-VD (r=-0.174, p=0.122), 
or IPSS-total (r=-0.197, p=0.079) (Table 3).
Comparing the domains of the IIEF-5 with each domain 
of the PEDT, questions 1, 4, and 5 of the PEDT were sig-
nificantly negatively correlated with all domains of the 
IIEF-5. The frequencies of the PE and ejaculation with min-
imal sexual stimulation domains were significantly corre-
lated with the intercourse satisfaction domain of the 
IIEF-5.
DISCUSSION
Ejaculation is triggered by efferent dopamine acting on the 
D2 receptors of central and spinal efferent fibers, which re-
lay information down to the sympathetic ganglia at T10-L2 
and the sacral fibers [6]. This stimulates pudendal nerve 
fibers from the S2-S4 region of the spinal cord, resulting 
in smooth muscle contractions of the prostate, seminal 
vesicles, vas deferens, and epididymis. This increases the 
volume and fluid content of semen, which is forced into the 
posterior urethra under the control of the sympathetic 
nervous system, producing emission [7].
The Diagnostic and Statistical Manual of Mental Disor-
ders, 4 edition, test revision (DSM-IV-TR) defines PE as 
“the persistence of recurrent ejaculation with minimal sex-
ual stimulation before, on, or shortly after penetration and 
before the person wishes it and it causes marked distress 
or interpersonal difficulty and is not due to the direct effects 
of a substance” [8].
Primary PE (lifelong) occurs and persists from the first 
sexual encounter, whereas secondary PE (acquired) tran-
spires after a period of normal control of ejaculatory 
function. Primary PE likely has a genetic basis. One study 
reported that 91% of men with primary PE had a first-de-
gree relative with PE [9]. The approach to treating secon-
dary or acquired PE is to treat the underlying condition. 
Secondary PE is due to psychological or relationship prob-
lems, ED, prostatitis, or thyroid dysfunction [10]. The most 
common cause of secondary PE is declining erectile func-
tion, whereby rapid ejaculation becomes a compensatory 
mechanism, either consciously or unconsciously, for the in-
ability to maintain the erection. An alternative expla-
nation is that lower levels of NO and increased sympathetic 
tone, associated with aging, both predispose men to erectile 
failure and hasten ejaculation [11-13].Korean J Urol 2012;53:189-193
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The PEDT has been found to have a high level of agree-
ment with clinical diagnosis, and its test-retest reliability 
has been shown to be good, with an intra-class correlation 
coefficient of 0.88 [14]. The PEDT consists of five questions 
that address the following five domains: ejaculation con-
trol, frequency of PE, ejaculation with minimal sexual 
stimulation, distress, and interpersonal difficulty. Each 
question has five responses, and the scores of each question 
range from 0 to 4 with a minimum total score of 0 and a max-
imum score of 20. A low score suggests a low probability of 
having PE.
In the Premature Ejaculation Perceptions and Attitudes 
study, many countries did not show an increased preva-
lence of PE with increasing age [15]. However, according 
to the data of the Korean Society for Sexual Medicine and 
Andrology, Koreans demonstrate an increased PE preva-
lence with increasing age; these data support the above hy-
pothesis and concur with our data.
Our study confirmed that PE was correlated with ED. 
Furthermore, ejaculation with very little stimulation and 
the frequency of PE were not correlated with ED. 
Nevertheless, difficulty with ejaculation control was corre-
lated with ED. In particular, erection firmness and erection 
maintenance ability were correlated with the control of 
ejaculation, as seen in secondary PE.
The proposal has been made that the use of a PDE-5 in-
hibitor (e.g., sildenafil) may increase the level of NO cen-
trally (reducing sympathetic drive) and peripherally (lead-
ing to smooth muscle dilatation of the vas deferens and 
seminal vesicles, opposing sympathetic vasoconstriction), 
probably prolonging the intravaginal ejaculation latency 
time (IELT) in men with PE [16]. Nitric oxide synthase iso-
enzymes are present in human seminal vesicle smooth 
muscle, and the NO-cGMP and NO-cAMP signaling path-
ways are not only involved in the relaxation of human pen-
ile smooth muscles but also affect smooth muscle relaxa-
tion in the vas deferens, seminal vesicle, prostate, urethra, 
and skeletal muscles [17].
In a randomized placebo-controlled study of men with 
primary PE without ED, sildenafil did not significantly 
prolong the IELT, but it was associated with a perception 
of greater control over ejaculation in men receiving active 
therapy. Our cross-sectional study showed that an im-
provement in ED was correlated with an improvement in 
PE. However, we did not examine the correlation between 
the use of PDE-5 inhibitors and PE.
Several community-based studies have shown strong 
correlations between the prevalence of sexual dysfunction, 
especially ED, and the severity of LUTS with increasing 
age [1]. In our study, the IPSS-ST, IPSS-VD, IPSS-total, 
and PEDT scores were not significantly correlated with 
age. Only the IIEF-5 score had a significant correlation 
with age.
The pathophysiological mechanism of the correlations 
among LUTS, ED, and PE remains unclear, although sev-
eral hypotheses have been proposed [18-21]. One possible 
cause is overactivation of the autonomic nervous system 
and increased sympathetic nervous system activity. Accor-
ding to this hypothesis, LUTS could result from sym-
pathetic nervous system tone, which induces the occur-
rence of urinary storage symptoms owing to the contraction 
of smooth muscles in the prostate gland and urinary 
bladder. ED occurs as a result of smooth muscle contraction 
in the corpus cavernosum. PE occurs as a result of smooth 
muscle contraction in the prostate, seminal vesicle, vas def-
erens, and epididymis [18-21].
However, this hypothesis has not been confirmed in ex-
perimental studies. In our study, the PEDT score was sig-
nificantly correlated with the IPSS-ST, IPSS-total, and 
IIEF-5 scores in the 60 to 79 year-old age group. The PEDT 
score was significantly correlated with IPSS-ST; however, 
it was not correlated with IPSS-VD. PE seems to correlate 
with LUTS and erectile dysfunction, and storage symp-
toms seemed to be correlated with PE more than voiding 
symptoms in the 60 to 79 year-old men in our study. This 
is explained by the increased sympathetic tone in old age. 
Some LUTS result from increased sympathetic tone and 
storage symptoms, which were related more to the PEDT 
score, and are associated with increased sympathetic tone 
rather than voiding symptoms.
Irwin et al. [22] reported that an overactive bladder was 
significantly associated with an increased prevalence of 
ED and that sexual activity, sexual enjoyment, and sexual 
satisfaction were reduced as the result of urinary symp-
toms. In our study, however, the IIEF-5 score had the only 
significant correlation with the PEDT score. The IIEF-5 
score was not significantly correlated with the IPSS-ST, 
IPSS-VD, or IPSS-total. In fact, our previous study re-
vealed that the IIEF-5 score was significantly negatively 
correlated with the IPSS-total, especially IPSS-ST [23]. 
The reason for this difference can be explained by the fact 
that the population of the previous study consisted of pa-
tients with LUTS, whereas the population in the current 
study was a general population who did not visit the hospi-
tal at the time the questionnaire was administered. There-
fore, a smaller proportion of the population of this study 
complained of LUTS.
In recent years, many studies have reported that the ad-
ministration of alpha-blockers improves LUTS and sexual 
dysfunction [24,25]. Other studies have reported that not 
only the bladder neck, urethra, and prostate, but also the 
seminal vesicle and vas deferens show a typical distribu-
tion for alpha-adrenoceptors, which accounts for their ca-
pacity to affect ejaculation, as reported in clinical studies 
in men with prostatic hyperplasia (up to 7% of cases re-
ported with tamsulosin) [26]. Almost no reports have ad-
dressed the effects of antimuscarinic agents on sexual func-
tion in LUTS. Our study showed that PE was significantly 
correlated with LUTS, particularly storage symptoms, in 
the 60 to 79 year-old age group rather than the 50 to 69 
year-old age group. In our study, no information on the pa-
tients’ medical history was collected. To address this limi-
tation, a well-designed, larger-scale assessment of the rela-
tionship and treatment of LUTS, ED, and PE is warranted Korean J Urol 2012;53:189-193
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to validate the results of this study.
CONCLUSIONS
Korean middle-aged to elderly men frequently experience 
PE, which is significantly correlated with ED. In addition, 
LUTS, particularly storage symptoms, have a negative ef-
fect on PE. An improvement in storage symptoms could 
positively affect men with PE and ED, and the storage 
symptoms of LUTS may play an important role in the treat-
ment of PE in middle-aged to elderly Korean men.
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